Growth Metrics

Hni (HNI) EBITDA (2016 - 2026)

Hni (HNI) has disclosed EBITDA for 17 consecutive years, with $41.5 million as the latest value for Q3 2025.

  • On a quarterly basis, EBITDA fell 9.78% to $41.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $152.1 million, a 25.08% increase, with the full-year FY2026 number at $66.0 million, down 53.49% from a year prior.
  • EBITDA was $41.5 million for Q3 2025 at Hni, down from $56.7 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $59.1 million in Q4 2022 to a low of -$12.9 million in Q3 2023.
  • A 5-year average of $27.3 million and a median of $20.4 million in 2022 define the central range for EBITDA.
  • Peak YoY movement for EBITDA: crashed 144.48% in 2023, then skyrocketed 1017.65% in 2024.
  • Hni's EBITDA stood at $19.3 million in 2021, then rose by 5.7% to $20.4 million in 2022, then decreased by 0.49% to $20.3 million in 2023, then skyrocketed by 99.51% to $40.5 million in 2024, then grew by 2.47% to $41.5 million in 2025.
  • Per Business Quant, the three most recent readings for HNI's EBITDA are $41.5 million (Q3 2025), $56.7 million (Q2 2025), and $13.4 million (Q1 2025).